Breaking News

Monday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Usio announces uplisting to Nasdaq Global Market » 09:03
06/14/21
06/14
09:03
06/14/21
09:03
USIO

Usio

$6.45 /

-0.01 (-0.15%)

Usio announced that its…

Usio announced that its common shares have been approved for listing on the Nasdaq Global Market. Common shares will begin trading on the Nasdaq Global Market on June 15th under the company's current ticker symbol - USIO. "Uplisting our stock to the Nasdaq Global Market is an important milestone that builds on the positive momentum generated by our growing string of record transaction processing results," said Louis Hoch, President and CEO of Usio. "Along with increasing our visibility in the marketplace, we anticipate this uplisting to improve the liquidity of our stock, further broaden our institutional shareholder base and ultimately enhance long-term shareholder value. Additionally, we expect this uplisting to further enhance our ability to implement our multi-channel growth strategy and optimize the company's return on invested capital."

ShowHide Related Items >><<
USIO Usio
$6.45 /

-0.01 (-0.15%)

USIO Usio
$6.45 /

-0.01 (-0.15%)

03/30/21 Alliance Global Partners
Usio's Q4 gross margin not sustainable, says Alliance Global Partners
02/16/21 Alliance Global Partners
Usio shares 'over-bought' after 320% rally, says Alliance Global Partners
08/03/20 Alliance Global Partners
Alliance Global Partners downgrades Usio to Neutral, predicts 'weak' Q2 report
08/03/20 Alliance Global Partners
Usio downgraded to Neutral from Buy at Alliance Global Partners
USIO Usio
$6.45 /

-0.01 (-0.15%)

  • 23
    Sep
USIO Usio
$6.45 /

-0.01 (-0.15%)

USIO Usio
$6.45 /

-0.01 (-0.15%)

Over a week ago
Hot Stocks
Usio processes excess of $1B of transaction volume in May » 09:13
06/03/21
06/03
09:13
06/03/21
09:13
USIO

Usio

$6.03 /

+0.24 (+4.15%)

Usio announced that May…

Usio announced that May 2021 was the Company's first-ever month in which it processed in excess of $1B dollars of transaction volume. "Our ACH business is driving unprecedented growth," said Louis Hoch, President and Chief Executive Officer of Usio. "We had our best quarter of transaction processing volume in the fourth quarter of 2020, and in the first quarter of 2021 we doubled the dollar volume we processed in the fourth quarter of 2020. That alone is reason to celebrate, but in the first two months of the second quarter of 2021, our ACH business has already exceeded the first quarter's record number of transactions and dollar volume processed. And, now in May 2021, we achieved our first $1 billion processing month, with over $1.1 billion in transaction dollar volume processed, which speaks to the strength of the relationships we are building with organizations in fast-growing industries, such as cryptocurrency and FinTech lending. As always, we look to sustain this momentum by focusing on execution, investing in technology, and providing unparalleled service, all with an eye to deliver shareholder value."lume."Our ACH business is driving unprecedented growth," said Louis Hoch, President and Chief Executive Officer of Usio. "We had our best quarter of transaction processing volume in the fourth quarter of 2020, and in the first quarter of 2021 we doubled the dollar volume we processed in the fourth quarter of 2020. That alone is reason to celebrate, but in the first two months of the second quarter of 2021, our ACH business has already exceeded the first quarter's record number of transactions and dollar volume processed. And, now in May 2021, we achieved our first $1 billion processing month, with over $1.1 billion in transaction dollar volume processed, which speaks to the strength of the relationships we are building with organizations in fast-growing industries, such as cryptocurrency and FinTech lending. As always, we look to sustain this momentum by focusing on execution, investing in technology, and providing unparalleled service, all with an eye to deliver shareholder value."

ShowHide Related Items >><<
USIO Usio
$6.03 /

+0.24 (+4.15%)

USIO Usio
$6.03 /

+0.24 (+4.15%)

03/30/21 Alliance Global Partners
Usio's Q4 gross margin not sustainable, says Alliance Global Partners
02/16/21 Alliance Global Partners
Usio shares 'over-bought' after 320% rally, says Alliance Global Partners
08/03/20 Alliance Global Partners
Alliance Global Partners downgrades Usio to Neutral, predicts 'weak' Q2 report
08/03/20 Alliance Global Partners
Usio downgraded to Neutral from Buy at Alliance Global Partners
USIO Usio
$6.03 /

+0.24 (+4.15%)

  • 23
    Sep
USIO Usio
$6.03 /

+0.24 (+4.15%)

USIO Usio
$6.03 /

+0.24 (+4.15%)

Over a month ago
Earnings
Usio reports Q1 EPS (4c), consensus (3c) » 16:18
05/13/21
05/13
16:18
05/13/21
16:18
USIO

Usio

$5.08 /

-0.11 (-2.12%)

Reports Q1 revenue…

Reports Q1 revenue $13.46M, consensus $12.11M. Louis Hoch, president and CEO of Usio, said, "The new year is off to a terrific start, with first quarter revenues growing at the fastest rate in the Company's history, leading to all-time record quarterly revenues and a significant improvement in profitability. Once again, results illustrate that our multi-channel distribution strategy is successfully capitalizing on the vast opportunities in the fast-growing electronic payments and related industries with over 100% growth in the Company's operating performance metrics (Key Performance Indicators or KPIs) in our ACH, Card and Prepaid Businesses. Given the significant increase in the sequential rate of revenue growth compared to the fourth quarter of 2020, we are extremely confident our business is gaining momentum. We remain on pace to achieve, or exceed, our 50% revenue growth goal for this year."

ShowHide Related Items >><<
USIO Usio
$5.08 /

-0.11 (-2.12%)

USIO Usio
$5.08 /

-0.11 (-2.12%)

03/30/21 Alliance Global Partners
Usio's Q4 gross margin not sustainable, says Alliance Global Partners
02/16/21 Alliance Global Partners
Usio shares 'over-bought' after 320% rally, says Alliance Global Partners
08/03/20 Alliance Global Partners
Alliance Global Partners downgrades Usio to Neutral, predicts 'weak' Q2 report
08/03/20 Alliance Global Partners
Usio downgraded to Neutral from Buy at Alliance Global Partners
USIO Usio
$5.08 /

-0.11 (-2.12%)

  • 23
    Sep
USIO Usio
$5.08 /

-0.11 (-2.12%)

USIO Usio
$5.08 /

-0.11 (-2.12%)

Hot Stocks
Usio reports Q1 credit card dollars processed up 30% » 09:11
04/26/21
04/26
09:11
04/26/21
09:11
USIO

Usio

$6.48 /

+0.17 (+2.69%)

First Quarter Processing…

First Quarter Processing Results: Credit Card Dollars Processed + 30%; Credit Card Transactions Processed + 105%; Prepaid Card Load Volume + 105%; Prepaid Card Transaction Volume + 89%. More ACH and Card transactions were processed in the first quarter of 2021 than any previous quarter in the company's history. Total Dollars processed in the first quarter of 2021 were $1.86 billion, topping the previous all-time record of $920 million that was set in fourth quarter of 2020. Louis Hoch, President and CEO of Usio, said, "First quarter electronic payments and dollar transaction processing volume was more than double our previous record quarter, which was set in the fourth quarter of 2020. These two consecutive quarters of record dollars processed clearly indicates our business has inflected, and we have now been consistently operating at a significantly higher level of activity. There has been a doubling of key performance metrics in each of our segments, with ACH electronic check dollars processed up 139%, and credit card transactions processed and prepaid load volume both up 105%. The new year is off to a great start and we are capitalizing on the strong business momentum by continuing to invest in our growth platforms to further strengthen the Usio franchise."

ShowHide Related Items >><<
USIO Usio
$6.48 /

+0.17 (+2.69%)

USIO Usio
$6.48 /

+0.17 (+2.69%)

03/30/21 Alliance Global Partners
Usio's Q4 gross margin not sustainable, says Alliance Global Partners
02/16/21 Alliance Global Partners
Usio shares 'over-bought' after 320% rally, says Alliance Global Partners
08/03/20 Alliance Global Partners
Alliance Global Partners downgrades Usio to Neutral, predicts 'weak' Q2 report
08/03/20 Alliance Global Partners
Usio downgraded to Neutral from Buy at Alliance Global Partners
USIO Usio
$6.48 /

+0.17 (+2.69%)

  • 23
    Sep
USIO Usio
$6.48 /

+0.17 (+2.69%)

USIO Usio
$6.48 /

+0.17 (+2.69%)

Conference/Events
Usio management to meet virtually with Barrington » 04:55
04/13/21
04/13
04:55
04/13/21
04:55
USIO

Usio

$7.15 /

+0.54 (+8.17%)

Virtual Meeting to be…

Virtual Meeting to be held on April 13 hosted by Barrington.

ShowHide Related Items >><<
USIO Usio
$7.15 /

+0.54 (+8.17%)

USIO Usio
$7.15 /

+0.54 (+8.17%)

03/30/21 Alliance Global Partners
Usio's Q4 gross margin not sustainable, says Alliance Global Partners
02/16/21 Alliance Global Partners
Usio shares 'over-bought' after 320% rally, says Alliance Global Partners
08/03/20 Alliance Global Partners
Alliance Global Partners downgrades Usio to Neutral, predicts 'weak' Q2 report
08/03/20 Alliance Global Partners
Usio downgraded to Neutral from Buy at Alliance Global Partners
USIO Usio
$7.15 /

+0.54 (+8.17%)

  • 23
    Sep
USIO Usio
$7.15 /

+0.54 (+8.17%)

USIO Usio
$7.15 /

+0.54 (+8.17%)

Hot Stocks
Usio expects over 100% y-o-y growth in Q1 electronic payments volume » 09:06
04/12/21
04/12
09:06
04/12/21
09:06
USIO

Usio

$6.61 /

+0.11 (+1.69%)

Usio announced that it…

Usio announced that it expects to report record processing results for the first quarter of 2021. Louis Hoch, President and CEO of Usio, said, "I am pleased to report that through our diverse payment channel strategy, all three of our segments, ACH, Card and Prepaid, are expected to report over 100% year-over-year growth in important Key Performance Metrics. This generated all-time record quarterly volume for dollars processed for the first three months of 2021. This is an excellent start to a year in which we expect to see revenue growth of 50% and a significant improvement in our profitability metrics." These results are based in part on preliminary results. Usio plans to release final transaction and processing volume results for the first quarter at a later date.

ShowHide Related Items >><<
USIO Usio
$6.61 /

+0.11 (+1.69%)

USIO Usio
$6.61 /

+0.11 (+1.69%)

03/30/21 Alliance Global Partners
Usio's Q4 gross margin not sustainable, says Alliance Global Partners
02/16/21 Alliance Global Partners
Usio shares 'over-bought' after 320% rally, says Alliance Global Partners
08/03/20 Alliance Global Partners
Alliance Global Partners downgrades Usio to Neutral, predicts 'weak' Q2 report
08/03/20 Alliance Global Partners
Usio downgraded to Neutral from Buy at Alliance Global Partners
USIO Usio
$6.61 /

+0.11 (+1.69%)

  • 23
    Sep
USIO Usio
$6.61 /

+0.11 (+1.69%)

USIO Usio
$6.61 /

+0.11 (+1.69%)

Conference/Events
Usio management to meet virtually with Barrington » 12:22
04/08/21
04/08
12:22
04/08/21
12:22
USIO

Usio

$6.35 /

+0.05 (+0.79%)

Virtual Meeting to be…

Virtual Meeting to be held on April 13 hosted by Barrington.

ShowHide Related Items >><<
USIO Usio
$6.35 /

+0.05 (+0.79%)

USIO Usio
$6.35 /

+0.05 (+0.79%)

03/30/21 Alliance Global Partners
Usio's Q4 gross margin not sustainable, says Alliance Global Partners
02/16/21 Alliance Global Partners
Usio shares 'over-bought' after 320% rally, says Alliance Global Partners
08/03/20 Alliance Global Partners
Alliance Global Partners downgrades Usio to Neutral, predicts 'weak' Q2 report
08/03/20 Alliance Global Partners
Usio downgraded to Neutral from Buy at Alliance Global Partners
USIO Usio
$6.35 /

+0.05 (+0.79%)

  • 23
    Sep
USIO Usio
$6.35 /

+0.05 (+0.79%)

USIO Usio
$6.35 /

+0.05 (+0.79%)

Recommendations
Usio's Q4 gross margin not sustainable, says Alliance Global Partners » 13:08
03/30/21
03/30
13:08
03/30/21
13:08
USIO

Usio

$5.90 /

-0.38 (-6.05%)

Alliance Global Partners…

Alliance Global Partners analyst Brian Kinstlinger noted that Usio reported Q4 revenue that beat his estimate and an adjusted EBITDA of $256,000, compared to his estimate for a loss of $350,000. However, he expects the company's gross margin will pull back from the "impressive" result in Q4 and Kinstlinger keeps a Neutral rating and $3.75 price target on Usio shares.

ShowHide Related Items >><<
USIO Usio
$5.90 /

-0.38 (-6.05%)

USIO Usio
$5.90 /

-0.38 (-6.05%)

02/16/21 Alliance Global Partners
Usio shares 'over-bought' after 320% rally, says Alliance Global Partners
08/03/20 Alliance Global Partners
Alliance Global Partners downgrades Usio to Neutral, predicts 'weak' Q2 report
08/03/20 Alliance Global Partners
Usio downgraded to Neutral from Buy at Alliance Global Partners
05/07/20
Fly Intel: Top five analyst initiations
USIO Usio
$5.90 /

-0.38 (-6.05%)

  • 23
    Sep
USIO Usio
$5.90 /

-0.38 (-6.05%)

USIO Usio
$5.90 /

-0.38 (-6.05%)

On The Fly
Fly Intel: After-Hours Movers » 18:47
03/29/21
03/29
18:47
03/29/21
18:47
ABCL

AbCellera

$23.29 /

-1.5 (-6.05%)

, VTSI

VirTra

$4.75 /

+0.05 (+1.06%)

, SRAX

Srax

$4.50 /

+0.315 (+7.54%)

, BIOC

Biocept

$5.15 /

-0.545 (-9.58%)

, LYRA

Lyra Therapeutics

$11.30 /

-0.62 (-5.20%)

, PLMR

Palomar

$65.96 /

-3.44 (-4.96%)

, PSNL

Personalis

$20.77 /

-1.28 (-5.80%)

, SHAK

Shake Shack

$110.70 /

-3.84 (-3.35%)

, PCVX

Vaxcyte

$22.76 /

-1.02 (-4.29%)

, DNMR

Danimer Scientific

$36.99 /

-1.605 (-4.16%)

, CLDX

Celldex

$20.50 /

-3.51 (-14.62%)

, GOEV

Canoo

$11.74 /

-0.72 (-5.78%)

, USIO

Usio

$6.31 /

-0.39 (-5.82%)

, WVE

Wave Life Sciences

$7.09 /

-0.22 (-3.01%)

, BFLY

Butterfly Network

$18.09 /

+0.09 (+0.50%)

, YTEN

Yield10 Bioscience

$11.68 /

-0.7 (-5.65%)

Check out this evening's…

ShowHide Related Items >><<
YTEN Yield10 Bioscience
$11.68 /

-0.7 (-5.65%)

WVE Wave Life Sciences
$7.09 /

-0.22 (-3.01%)

VTSI VirTra
$4.75 /

+0.05 (+1.06%)

USIO Usio
$6.31 /

-0.39 (-5.82%)

SRAX Srax
$4.50 /

+0.315 (+7.54%)

SHAK Shake Shack
$110.70 /

-3.84 (-3.35%)

PSNL Personalis
$20.77 /

-1.28 (-5.80%)

PLMR Palomar
$65.96 /

-3.44 (-4.96%)

PCVX Vaxcyte
$22.76 /

-1.02 (-4.29%)

LYRA Lyra Therapeutics
$11.30 /

-0.62 (-5.20%)

GOEV Canoo
$11.74 /

-0.72 (-5.78%)

DNMR Danimer Scientific
$36.99 /

-1.605 (-4.16%)

CLDX Celldex
$20.50 /

-3.51 (-14.62%)

BIOC Biocept
$5.15 /

-0.545 (-9.58%)

BFLY Butterfly Network
$18.09 /

+0.09 (+0.50%)

ABCL AbCellera
$23.29 /

-1.5 (-6.05%)

ABCL AbCellera
$23.29 /

-1.5 (-6.05%)

03/24/21 BMO Capital
AbCellera price target lowered to $59 from $61 at BMO Capital
02/08/21 SVB Leerink
AbCellera price target raised to $52 from $45 at SVB Leerink
01/26/21 Berenberg
Eli Lilly data 'incrementally positive' for AbCellera, says Berenberg
01/25/21 BMO Capital
AbCellera price target raised to $61 from $48 at BMO Capital
VTSI VirTra
$4.75 /

+0.05 (+1.06%)

02/12/21 Maxim
VirTra assumed with a Buy at Maxim
05/13/20
Fly Intel: Top five analyst initiations
05/13/20 Roth Capital
VirTra resumed with a Buy at Roth Capital
SRAX Srax
$4.50 /

+0.315 (+7.54%)

02/12/21 B. Riley
Srax price target raised to $7.50 from $4.50 at B. Riley Securities
02/08/21 Ladenburg
Srax initiated with a Buy at Ladenburg
01/29/21 B. Riley
Srax price target raised to $4.50 from $4 at B. Riley Securities
07/06/20
Fly Intel: Top five analyst initiations
BIOC Biocept
$5.15 /

-0.545 (-9.58%)

08/13/20 Maxim
Biocept price target raised to $2 from $1 at Maxim
05/14/20 Brookline
Biocept initiated with a Buy at Brookline
LYRA Lyra Therapeutics
$11.30 /

-0.62 (-5.20%)

12/07/20 BofA
Lyra Therapeutics price target raised to $26 from $19 at BofA
05/26/20 BTIG
Lyra Therapeutics initiated with a Buy at BTIG
05/26/20 Jefferies
Jefferies starts Lyra Therapeutics at Buy with $24 price target
05/26/20 BofA
BofA starts Lyra Therapeutics at Buy with $21 price target
PLMR Palomar
$65.96 /

-3.44 (-4.96%)

03/26/21
Fly Intel: Top five analyst upgrades
03/26/21 Barclays
Palomar upgraded to Overweight from Equal Weight at Barclays
02/23/21 Keefe Bruyette
Palomar recent selloff on Uri 'very overdone,' says Keefe Bruyette
01/12/21 Barclays
Palomar price target raised to $94 from $82 at Barclays
PSNL Personalis
$20.77 /

-1.28 (-5.80%)

02/26/21
Fly Intel: Top five analyst initiations
02/26/21 Needham
Personalis assumed with a Buy at Needham
01/27/21 Truist
Personalis initiated with a Buy at Truist
01/04/21 BofA
Personalis downgraded to Neutral on valuation at BofA
SHAK Shake Shack
$110.70 /

-3.84 (-3.35%)

03/18/21 Truist
Shake Shack price target raised to $105 from $99 at Truist
03/04/21 Deutsche Bank
Shake Shack price target raised to $107 from $70 at Deutsche Bank
02/26/21 Loop Capital
Shake Shack price target raised to $150 from $120 at Loop Capital
02/26/21 Barclays
Shake Shack price target raised to $100 from $86 at Barclays
PCVX Vaxcyte
$22.76 /

-1.02 (-4.29%)

07/16/20 Wells Fargo
Sutro Biopharma initiated with an Overweight at Wells Fargo
07/07/20
Fly Intel: Top five analyst initiations
07/07/20 BofA
Vaxcyte initiated with a Buy at BofA
07/07/20 Jefferies
Vaxcyte initiated with a Buy at Jefferies
DNMR Danimer Scientific
$36.99 /

-1.605 (-4.16%)

02/09/21 Jefferies
Danimer Scientific price target raised to $66 from $49 at Jefferies
01/06/21 Jefferies
Danimer Scientific initiated with a Buy at Jefferies
CLDX Celldex
$20.50 /

-3.51 (-14.62%)

03/29/21 H.C. Wainwright
Celldex selloff on CDX-0159 data 'undeserved,' says H.C. Wainwright
02/23/21 H.C. Wainwright
Celldex price target raised to $36 from $25 at H.C. Wainwright
02/23/21 Cantor Fitzgerald
Celldex price target raised to $35 from $22 at Cantor Fitzgerald
10/19/20 H.C. Wainwright
Celldex price target raised to $25 from $16 at H.C. Wainwright
GOEV Canoo
$11.74 /

-0.72 (-5.78%)

03/11/21 R.F. Lafferty
Canoo initiated with a Buy at R.F. Lafferty
USIO Usio
$6.31 /

-0.39 (-5.82%)

02/16/21 Alliance Global Partners
Usio shares 'over-bought' after 320% rally, says Alliance Global Partners
08/03/20 Alliance Global Partners
Alliance Global Partners downgrades Usio to Neutral, predicts 'weak' Q2 report
08/03/20 Alliance Global Partners
Usio downgraded to Neutral from Buy at Alliance Global Partners
05/07/20
Fly Intel: Top five analyst initiations
WVE Wave Life Sciences
$7.09 /

-0.22 (-3.01%)

03/23/21 Truist
Truist sees mixed readthroughs to Wave's toplines from competitor HD setback
03/11/21 Mizuho
Wave Life Sciences price target raised to $21 from $19 at Mizuho
12/15/20 H.C. Wainwright
Wave Life Sciences assumed with a Buy at H.C. Wainwright
11/20/20 Mizuho
Wave Life Sciences price target lowered to $19 from $21 at Mizuho
BFLY Butterfly Network
$18.09 /

+0.09 (+0.50%)

YTEN Yield10 Bioscience
$11.68 /

-0.7 (-5.65%)

02/10/21 Maxim
Yield10 Bioscience price target raised to $24 from $12 at Maxim
02/09/21 Maxim
Yield10 Bioscience price target raised to $24 from $12 at Maxim
01/19/21 H.C. Wainwright
Yield10 Bioscience proof-of-concept validates pipeline, says H.C. Wainwright
09/10/20 H.C. Wainwright
Yield10 Bioscience initiated with a Buy at H.C. Wainwright
YTEN Yield10 Bioscience
$11.68 /

-0.7 (-5.65%)

WVE Wave Life Sciences
$7.09 /

-0.22 (-3.01%)

VTSI VirTra
$4.75 /

+0.05 (+1.06%)

USIO Usio
$6.31 /

-0.39 (-5.82%)

SRAX Srax
$4.50 /

+0.315 (+7.54%)

SHAK Shake Shack
$110.70 /

-3.84 (-3.35%)

PSNL Personalis
$20.77 /

-1.28 (-5.80%)

PLMR Palomar
$65.96 /

-3.44 (-4.96%)

PCVX Vaxcyte
$22.76 /

-1.02 (-4.29%)

LYRA Lyra Therapeutics
$11.30 /

-0.62 (-5.20%)

GOEV Canoo
$11.74 /

-0.72 (-5.78%)

CLDX Celldex
$20.50 /

-3.51 (-14.62%)

BIOC Biocept
$5.15 /

-0.545 (-9.58%)

BFLY Butterfly Network
$18.09 /

+0.09 (+0.50%)

ABCL AbCellera
$23.29 /

-1.5 (-6.05%)

  • 01
    Feb
  • 27
    Jan
  • 11
    Dec
  • 23
    Sep
  • 23
    Sep
  • 12
    Aug
  • 24
    Jun
  • 16
    Jun
  • 12
    Jun
  • 01
    May
  • 14
    Apr
GOEV Canoo
$11.74 /

-0.72 (-5.78%)

DNMR Danimer Scientific
$36.99 /

-1.605 (-4.16%)

WVE Wave Life Sciences
$7.09 /

-0.22 (-3.01%)

USIO Usio
$6.31 /

-0.39 (-5.82%)

SRAX Srax
$4.50 /

+0.315 (+7.54%)

SHAK Shake Shack
$110.70 /

-3.84 (-3.35%)

PSNL Personalis
$20.77 /

-1.28 (-5.80%)

PLMR Palomar
$65.96 /

-3.44 (-4.96%)

GOEV Canoo
$11.74 /

-0.72 (-5.78%)

DNMR Danimer Scientific
$36.99 /

-1.605 (-4.16%)

CLDX Celldex
$20.50 /

-3.51 (-14.62%)

BIOC Biocept
$5.15 /

-0.545 (-9.58%)

BFLY Butterfly Network
$18.09 /

+0.09 (+0.50%)

ABCL AbCellera
$23.29 /

-1.5 (-6.05%)

SHAK Shake Shack
$110.70 /

-3.84 (-3.35%)

GOEV Canoo
$11.74 /

-0.72 (-5.78%)

DNMR Danimer Scientific
$36.99 /

-1.605 (-4.16%)

BIOC Biocept
$5.15 /

-0.545 (-9.58%)

BFLY Butterfly Network
$18.09 /

+0.09 (+0.50%)

ABCL AbCellera
$23.29 /

-1.5 (-6.05%)

Earnings
Usio reports Q4 EPS 1c, consensus (5c) » 16:07
03/29/21
03/29
16:07
03/29/21
16:07
USIO

Usio

$6.12 /

-0.58 (-8.66%)

Reports Q4 revenue…

Reports Q4 revenue $9.38M, consensus $8.59M. Louis Hoch, President and Chief Executive Officer of Usio, said, "Fourth quarter results once again illustrated the strength of our multi-channel distribution strategy and the momentum it is creating. Revenue growth in the quarter accelerated to 27.4%, driven primarily by strong growth in our prepaid business, an increase in card revenues and a one-month contribution from Output Solutions, which was acquired late in the quarter. This strong growth also demonstrated the leverage in our model, as gross profits were up 62.7%, we generated an $800,000 improvement at the operating income (loss) compared to the same quarter a year ago and we achieved adjusted EBITDA positive cash flow in Q4. We ended the year in a strong financial position, which will enable us to continue to invest in our technology, sales and marketing initiatives to further capitalize on growth opportunities and drive shareholder value." "We are extremely excited by the prospect for even faster growth in calendar year 2021. Looking across the enterprise, our PayFac business has inflected with PayFac's single largest customer/client now rapidly boarding and improved conversion rates throughout our growing portfolio of ISV relationships. Our Prepaid business has established a new, higher level of performance, and we are preparing for the next leg up. Our new line of business, Usio Output Solutions should significantly add to this year's performance, with the opportunity to generate even better performance through the dynamic cross-selling opportunities it creates as a complement to our other businesses. And, most importantly, in our ACH business, our relationships with leading organizations in fast-growing industries like cryptocurrency should drive strong growth in our most profitable segment and is back on track for year-over-year growth in the first quarter of 2021. As a result, revenues should be up significantly and we should achieve positive cash flow this year. In each of our segments, our success stems from our winning formula of innovative technology and unparalleled service, which continues to provide a differentiated, competitive advantage across the electronic payments landscape."

ShowHide Related Items >><<
USIO Usio
$6.12 /

-0.58 (-8.66%)

USIO Usio
$6.12 /

-0.58 (-8.66%)

02/16/21 Alliance Global Partners
Usio shares 'over-bought' after 320% rally, says Alliance Global Partners
08/03/20 Alliance Global Partners
Alliance Global Partners downgrades Usio to Neutral, predicts 'weak' Q2 report
08/03/20 Alliance Global Partners
Usio downgraded to Neutral from Buy at Alliance Global Partners
05/07/20
Fly Intel: Top five analyst initiations
USIO Usio
$6.12 /

-0.58 (-8.66%)

  • 23
    Sep
USIO Usio
$6.12 /

-0.58 (-8.66%)

USIO Usio
$6.12 /

-0.58 (-8.66%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.